Postdoc Position at Imperial College London

Imperial College London, UK is inviting excellent candidates to apply for a postdoctoral scholar position. This position is closed on December 13, 2018.

The Centre for Health Economics & Policy Innovation (CHEPI) at Imperial College Business School has received funding from the European Commission to participate in a project on innovative methods to support future policy decisions around rare diseases.

Foresight in Rare Disease Policy (RARE2030), is a two-year project involving eight partners across four European countries. The project aims to guide future rare disease policy by using the participatory foresight approach and other innovative methods to build consensus and encourage uptake by all relevant stakeholders, with a focus on policy makers.

We wish to appoint a Research Associate to work within CHEPI to capture the complex interaction between multiple factors and drivers influencing rare disease governance, assess the impact and costs of different policy options, and evaluate the potential future dynamics of rare disease drivers at 2030. The research and development pipeline of the rare disease therapeutic market will then be mapped to identify potential gaps. The gaps can then be targeted by incentive policies to promote the development of new drugs.

You will work as part of an international multidisciplinary research team, where you will take the lead on developing an understanding of the economic literature on innovation for orphan drugs and develop an understanding of the orphan drug market for rare diseases to identify areas requiring further development. You will quantify innovation of orphan drugs and the stock of potential innovations to be made available in the next decade in the absence of changes to the current incentive and regulatory framework. You will measure the determinants of innovation and market launch of orphan drugs and test how this is shaped by regulation and policy. You will identify novel incentive schemes that can be applied to promote the development of innovative therapies for rare diseases. In collaboration with partners in the project, you will build alternative futures (scenarios) based on influencing trends for the future care and governance of rare diseases. These scenarios will then be used in concert with the identified incentive schemes to provide recommendations to and stimulate debate among policy-makers and stakeholders.

Please see the Job Description for a full list of requirements.

The position is full time and fixed term for 15 months. Candidates must be able to commence the post by January 2019.

Should you require any further details on the role please contact: Professor Franco Sassi or Dr Marisa Miraldo

Should you have any queries on the application process please contact:

The College cannot apply for a Certificate of Sponsorship for this post under Tier 2 of the UKVI Points Based System. Any candidate, who is considering applying for this position and requires sponsorship, must ensure that they are able to obtain permission to work in the UK through an alternative immigration route.

The College is a proud signatory to the San-Francisco Declaration on Research Assessment (DORA), which means that in hiring and promotion decisions, we evaluate applicants on the quality of their work, not the journal impact factor where it is published.For more information, see

The College believes that the use of animals in research is vital to improve human and animal health and welfare. Animals may only be used in research programmes where their use is shown to be necessary for developing new treatments and making medical advances. Imperial is committed to ensuring that, in cases where this research is deemed essential, all animals in the College's care are treated with full respect, and that all staff involved with this work show due consideration at every level.


Get latest scholarships via your email! It's free!
Remember to check your email and active the subscription.
You can unsubscribe any time.
Copyright © 2015 All Right Reserved.